Skip to main content

A European Directive for clinical research

Intensive Care Medicine volume 29, pages 1818–1820 (2003)Cite this article

This is a preview of subscription content, access via your institution.

Access options

Buy single article

Instant access to the full article PDF.

43,34 €

Price includes VAT (Finland)
Tax calculation will be finalised during checkout.

References

  1. European Parliament (2001) Directive 2001/20/EC of the European Parliament and Council of 4 April 2001. Official Journal L121:34–44

    Google Scholar 

  2. Horton R (1999) Time to register randomized trials. BMJ 319:865–866

    CAS  PubMed  Google Scholar 

  3. Tonks A (2002) A clinical trials register for Europe. BMJ 325:1314–1315

    PubMed  Google Scholar 

  4. Mann H (2002) Research ethics committees and public dissemination of clinical trial results. Lancet 359:406–408

    PubMed  Google Scholar 

  5. Levine R (1986) Ethics and regulation of clinical research, 2nd edn. Urban and Schwarzenberg, Baltimore

  6. Lacombe D (1998) Insuring international clinical trials: an Academic viewpoint. Appl Clin Trials 8:24–29

    Google Scholar 

  7. Ferrand E, Bachoud-Levi AC, Rodrigues M, Maggiore S, Brun-Buisson C, Lemaire F (2001) Decision-making capacity and surrogate designation in French ICU patients. Intensive Care Med 27:1360–1364

    CAS  PubMed  Google Scholar 

  8. Dijk Y van, van der Voort PH, Kuiper MA, Kesecioglu J (2003) Research on subjects incompetent of giving informed consent: the situation in Dutch intensive care departments. Intensive Care Med (in press)

    Google Scholar 

  9. British Medical Association (1999) Withholding and withdrawing life-prolonging medical treatments: guidance for decision making. BMJ, London

  10. United States Food and Drug Administration (1996) Protection of human subjects: informed consent and waiver of informed consent in certain emergency research; final rules. Federal Register 51497-51531

    Google Scholar 

  11. Luce J (2003) California's new law allowing surrogate consent for clinical research involving subjects with impaired decision-making capacity. Intensive Care Med 29:1024–1025

    Google Scholar 

  12. Visser H (2001) Non therapeutic research in the EU in adults incapable of giving consent? Lancet 357:818–819

    CAS  PubMed  Google Scholar 

  13. Lemaire F (2002) Clinical research in the ICU; an official statement of the ESICM. Intensive Care Med 28:1218–1219

    Article  Google Scholar 

  14. Ster F, Singer E, Böttiger B, Chamberlain D, Baskett P, Bossaert L, Steen P (2002) A serious threat to evidence based resuscitation within the European Union. Resuscitation 53:237–238

    PubMed  Google Scholar 

  15. Watson R (2003) EU legislation threatens clinical trials. BMJ 326:1348

    PubMed  Google Scholar 

Download references

Author information

Affiliations

  1. Institution 1 Hop henri Mondor, Assistance publique de Paris Val de Marne, University of Paris 12, Créteil, France

    François J. P. Lemaire

Authors
  1. François J. P. Lemaire
    View author publications

    You can also search for this author in PubMed Google Scholar

Consortia

and an ESICM Task Force

Corresponding author

Correspondence to François J. P. Lemaire.

Additional information

Electronic Supplementary Material

Supplementary material is available in the online version of this article at http://dx.doi.org/10.1007/s00134-003-1963-0

Electronic Supplementary Material

Rights and permissions

Reprints and Permissions

About this article

Cite this article

Lemaire, F.J.P., and an ESICM Task Force. A European Directive for clinical research. Intensive Care Med 29, 1818–1820 (2003). https://doi.org/10.1007/s00134-003-1963-0

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00134-003-1963-0

Keywords

  • Medicinal Product
  • Competent Authority
  • Legal Representative
  • Surrogate Decision Maker
  • Investigational Medicinal Product